Please find the attached Newspaper Intimation for Publication of Results for September 2025 Quarter
Awaiting price reaction for this filing.
Cresanto Global Ltd has informed BSE that it has published its standalone unaudited financial results for the second quarter and half-year ended 30 September 2025 in Business Standard (English and Hindi) on 7 November 2025. The results were reviewed by the Audit Committee and approved by the Board on 5 November 2025 and are signed by Managing Director Prashant Nathmal Bajaj. The detailed results have been filed with BSE under Regulation 33 of SEBI LODR and are accessible on www.bseindia.com and the company's website www.raymedlab.com, as well as via a QR code in the published advertisement. This is a routine compliance intimation under Regulation 30 and 47(3) of SEBI LODR, and no specific financial numbers (revenue, profit, EPS) are disclosed in this filing itself — those are contained in the separate detailed results filed on BSE.
This is a standard regulatory disclosure with no fresh information beyond confirming that the Q2/H1 results have been publicly published. Investors should refer to the actual unaudited financial results on BSE for the underlying numbers; share price is unlikely to move on this notice alone unless the underlying results surprise meaningfully.